XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Loan and Security Agreement - Additional Information (Details) - USD ($)
9 Months Ended
Sep. 09, 2022
Sep. 30, 2023
Debt Instrument [Line Items]    
Debt instrument drew   $ 30,000,000
Default interest rate 5.00%  
K2 Health Ventures [Member]    
Debt Instrument [Line Items]    
Principal amount $ 60,000,000  
Facility fee $ 400,000  
Additional principal amount percentage 1.00%  
Term loan maturity date Sep. 01, 2026  
Interest only payment term 24 months  
Interest only payment extended term 36 months  
Contractual interest rate 8.75%  
Interest rate 9.90% 9.90%
Conversion price $ 4.785  
Final fee 6.00%  
Covenant terms   During the term of the Loan Agreement, the Company must maintain minimum unrestricted cash and cash equivalents equal to 5.0 times the average monthly cash burn measured over the trailing three-month period.
K2 Health Ventures [Member] | Prime Rate [Member]    
Debt Instrument [Line Items]    
Prime rate 4.75%  
Tranche One [Member] | K2 Health Ventures [Member]    
Debt Instrument [Line Items]    
Debt instrument drew $ 30,000,000  
Tranche Two [Member] | K2 Health Ventures [Member]    
Debt Instrument [Line Items]    
Debt instrument remaining borrowing capacity 10,000,000  
Tranche Three [Member] | K2 Health Ventures [Member]    
Debt Instrument [Line Items]    
Debt instrument remaining borrowing capacity $ 20,000,000  
Maximum [Member] | K2 Health Ventures [Member]    
Debt Instrument [Line Items]    
Prepayment fee range 4.00%  
Minimum [Member] | K2 Health Ventures [Member]    
Debt Instrument [Line Items]    
Prepayment fee range 1.00%  
Covenant Terms, Unrestricted Cash and Cash Equivalents   $ 5,000,000